Panagora Asset Management’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-95,203
| Closed | -$1.92M | – | 1779 |
|
|
2021
Q3 | $1.92M | Buy |
95,203
+57,365
| +152% | +$1.16M | 0.01% | 700 |
|
|
2021
Q2 | $1.41M | Sell |
37,838
-156,328
| -81% | -$5.83M | 0.01% | 843 |
|
|
2021
Q1 | $4.97M | Sell |
194,166
-106,338
| -35% | -$2.72M | 0.03% | 468 |
|
|
2020
Q4 | $6.62M | Buy |
300,504
+228,035
| +315% | +$5.02M | 0.04% | 371 |
|
|
2020
Q3 | $1.3M | Sell |
72,469
-63,842
| -47% | -$1.15M | 0.01% | 809 |
|
|
2020
Q2 | $3.46M | Sell |
136,311
-248,756
| -65% | -$6.32M | 0.02% | 504 |
|
|
2020
Q1 | $7.07M | Buy |
385,067
+382,511
| +14,965% | +$7.03M | 0.05% | 279 |
|
|
2019
Q4 | $56K | Sell |
2,556
-89
| -3% | -$1.95K | ﹤0.01% | 1902 |
|
|
2019
Q3 | $38K | Buy |
+2,645
| New | +$38K | ﹤0.01% | 2009 |
|
|
2018
Q3 | – | Sell |
-99,233
| Closed | -$1.22M | – | 2493 |
|
|
2018
Q2 | $1.22M | Buy |
99,233
+91,700
| +1,217% | +$1.12M | ﹤0.01% | 1077 |
|
|
2018
Q1 | $72K | Hold |
7,533
| – | – | ﹤0.01% | 1935 |
|
|
2017
Q4 | $68K | Buy |
7,533
+3,215
| +74% | +$29K | ﹤0.01% | 1989 |
|
|
2017
Q3 | $25K | Sell |
4,318
-926
| -18% | -$5.36K | ﹤0.01% | 2155 |
|
|
2017
Q2 | $17K | Hold |
5,244
| – | – | ﹤0.01% | 2315 |
|
|
2017
Q1 | $18K | Buy |
+5,244
| New | +$18K | ﹤0.01% | 2198 |
|
|
2016
Q1 | – | Sell |
-6,819
| Closed | -$81K | – | 2363 |
|
|
2015
Q4 | $81K | Sell |
6,819
-2,560
| -27% | -$30.4K | ﹤0.01% | 1854 |
|
|
2015
Q3 | $77K | Buy |
9,379
+5,957
| +174% | +$48.9K | ﹤0.01% | 1882 |
|
|
2015
Q2 | $48K | Buy |
+3,422
| New | +$48K | ﹤0.01% | 2157 |
|